Mucolytic drugs: Towards a contraindication in infants;Les fluidifiants bronchiques: Vers une contre-indication chez le nourrisson

Archives de Pediatrie

Volumn 17, Issue 6, 2010, Pages 735-736

  Mourdi, N ^a   Dubus, J C ^b   Bavoux, F ^c   Boyer Gervoise, M ^d   Jean Pastor, M J ^d   Chalumeau, M ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b TIMONE HOSPITAL   (France)

^c Institut Cochin   (France)

^d Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CARBOCISTEINE; MUCOLYTIC AGENT;

ARTICLE; CHILD CARE; CHRONIC BRONCHITIS; DRUG CONTRAINDICATION; DRUG SURVEILLANCE PROGRAM; HUMAN; INFANT; PATHOPHYSIOLOGY; PRESCRIPTION; REIMBURSEMENT; RHINOPHARYNGITIS; SYMPTOMATOLOGY; TRACHEOBRONCHITIS;

ACETYLCYSTEINE; BRONCHITIS; CARBOCYSTEINE; CROSS-CULTURAL COMPARISON; DRUG TOXICITY; EUROPE; EXPECTORANTS; FRANCE; HUMANS; INFANT; RESPIRATORY TRACT INFECTIONS; RISK FACTORS;

EID: 77955036700     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(10)70084-1     Document Type: Article

References (10)

1. Duijvestijn Y.C., Mourdi N., Smucny J., et al. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev 2009, 1. CD003124.
2. Chalumeau M., Chéron G., Assathiany R., et al. Fluidifiants bronchiques dans les infections respiratoires aiguës du nourrisson: un problème pharmacoépidémiologique?. Arch Pediatr 2002, 9:1128-1136.
3. Duijvestijn Y.C., Gerritsen J., Brand P.L. Acetylcysteine in children with lung disorders prescribed by one-third of family physicians: no support in the literature. Ned Tijdschr Geneeskd 1997, 141:826-830.
4. Cazzato T., Pandolfini C., Campi R., et al. Drug prescribing in out-patient children in Southern Italy. Eur J Clin Pharmacol 2001, 57:611-616.
5. Sanz E.J., Boada J.N. Drug utilization by children in Tenerife Island. Eur J Clin Pharmacol 1988, 34:495-499.
6. Chalumeau M., Treluyer J.M., Salanave B., et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 2000, 83:502-505.
7. Halna M., Leblond P., Aissi E., et al. Impact de la conférence de consensus sur le traitement ambulatoire des bronchiolites du nourrisson. Presse Med 2005, 34:277-281.
8. Devaux M., Grandfils N., Sermet C. Déremboursement des mucolytiques et des expectorants: quel impact sur la prescription des généralistes?. Institut de recherche et documentation en économie de la santé - Questions d'économie de la santé 2007, 128:1-6.
9. Commission nationale de pharmacovigilance. Compte-rendu de la réunion du mardi 24 mars 2009, . http://www.afssaps.fr/.
10. David M., Luc-Vanuxen L., Loundou A., et al. Application de la Conférence de consensus sur la bronchiolite aiguë du nourrisson en médecine générale: évolution entre 2003 et 2008. Arch Pediatr 2010, 17:125-131.